Vivek G Sunkari

Vivek G Sunkari currently serves as a Global Operations Manager at Genentech, overseeing Early Phase R&D and Clinical Biomarker Research Operations since 2020. Prior to this, Sunkari was a Postdoctoral Researcher at Stanford University from 2013 to 2017, where multiple projects were developed to address dysregulated tissue repair and regeneration using various models. Co-founding LymeTek Inc. in 2017, Sunkari directed project management and operations, and later worked at BriaCell Therapeutics Corp. as Program Manager for R&D and Biomarker Operations, focusing on breast cancer cell therapy. Additional entrepreneurial experience includes co-founding Intact Life Sciences between 2018 and 2020. Past research roles include project leadership at Karolinska Institutet and a focus on diabetes and wound healing in multiple academic settings. Sunkari's educational background includes a Ph.D. from Stanford University.